Dual T cell receptor/chimeric antigen receptor engineered NK-92 cells targeting the HPV16 E6 oncoprotein and the tumor-associated antigen L1CAM exhibit enhanced cytotoxicity and specificity against tumor cells.

Quiros-Fernandez I, Liborio-Ramos S, Leifert L, Schonfelder B, Vlodavsky I, Cid-Arregui A
J Med Virol. 2024 May;96(5):e29630. doi: 10.1002/jmv.29630. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.